Buy daytrana transmerdal patch




Daytrana (methylphenidate) is a patch that’s placed on the skin that treats attention-deficit/ hyperactivity disorder (ADHD) in people ages 6 to 17 years old. It can help improve attention while calming impulsive and hyperactive behavior. It should be used as part of a total treatment program for ADHD, which may include counseling and other therapies.

What is Daytrana (methylphenidate) used for?

  • Attention-deficit/hyperactivity disorder (ADHD)

How Daytrana (methylphenidate) works

Daytrana (methylphenidate) is a central nervous system (brain) stimulant. It treats attention-deficit/hyperactivity disorder (ADHD) by adjusting norepinephrine and dopamine activity in the brain, which improves attention and changes behavior.

What are the risks and warnings for Daytrana (methylphenidate)?

Daytrana (methylphenidate) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.


Abuse and dependence

  • Risk factors: History of substance abuse | Alcoholism

Daytrana (methylphenidate) has a risk for abuse and dependence. Take only what is prescribed by your healthcare provider to lower the risk of dependence and overdose. Misusing this drug can cause it to stop working and can lead to serious mental health issues. Talk to your healthcare provider about alternative therapies, especially if you have a history of substance or alcohol dependence.


Serious or life-threatening heart problems

  • Risk factors: History of heart problems

People taking Daytrana (methylphenidate) have had heart attacks, strokes, and sudden deaths. Anyone with a history of heart problems shouldn’t use this medication. You or your child should be checked for heart problems before starting this medication. Watch out for unexplained fainting, chest pain, or shortness of breath that comes on with or without physical activity.


Aggressive behavior and psychiatric symptoms

  • Risk factors: History of psychotic episodes | History of bipolar disorder | History of Tourette’s syndrome

Taking a stimulant like Daytrana (methylphenidate) can worsen or cause hallucinations, delusions, and paranoia. It may also worsen or cause aggressive behavior and serious depression including suicide. Let your healthcare provider know if you or your child have experienced these issues in the past.


Long-term growth suppression

  • Risk factors: Children

Daytrana (methylphenidate) can lower appetite and slow growth, especially in children. Your child’s healthcare provider will regularly monitor their height and weight during treatment.



  • Risk factors: History of seizures

Daytrana (methylphenidate) raises your chances of having a seizure, especially if you have a history of seizure disorder. Before taking Daytrana (methylphenidate), talk to your healthcare provider if you or your child have had seizures before and are taking medications to control them.


Tingling and numbness of the hands and feet

Some people on Daytrana (methylphenidate) have reported problems with their blood circulation, especially in their hands and feet. This is rare and usually gets better once the medication is stopped. Talk to your healthcare provider if you or your child notice numbness, pain, tingling, or a cold feeling in your hands or feet.


Loss of skin color

  • Risk factors: Vitiligo

Some people on Daytrana (methylphenidate) have reported a loss of skin color at or around the application site where the patch was placed. The loss of skin color may be permanent, even after removing or stopping the patch. Let your healthcare provider know right away if you notice any skin color changes.


Prolonged erections (priapism)

Sometimes painful and prolonged erections have happened in people taking Daytrana (methylphenidate). If you or your child develop an erection that lasts more than 4 hours, get medical help right away.


There are no reviews yet.

Be the first to review “Buy daytrana transmerdal patch”

Your email address will not be published. Required fields are marked *